Compare CRTO & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRTO | BVS |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 923.5M | 982.2M |
| IPO Year | 2013 | 2016 |
| Metric | CRTO | BVS |
|---|---|---|
| Price | $17.00 | $13.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $34.00 | $14.00 |
| AVG Volume (30 Days) | 303.1K | ★ 499.4K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.95 | ★ 163.46 |
| EPS | 0.37 | ★ 0.52 |
| Revenue | ★ $2,296,692,000.00 | $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | $5.54 | $7.06 |
| P/E Ratio | $46.19 | ★ $25.00 |
| Revenue Growth | ★ 27.65 | N/A |
| 52 Week Low | $15.58 | $6.26 |
| 52 Week High | $25.29 | $15.89 |
| Indicator | CRTO | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 40.61 | 42.09 |
| Support Level | $16.57 | $7.25 |
| Resistance Level | $18.24 | $14.71 |
| Average True Range (ATR) | 0.55 | 0.43 |
| MACD | 0.06 | -0.20 |
| Stochastic Oscillator | 15.24 | 17.58 |
Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.